Hepatoprotective Potential of Caesalpinia bonducella: Molecular Insight

M. Bhatt, J. Malik
{"title":"Hepatoprotective Potential of Caesalpinia bonducella: Molecular Insight","authors":"M. Bhatt, J. Malik","doi":"10.36348/merjps.2022.v02i01.004","DOIUrl":null,"url":null,"abstract":"Abstract: Liver fibrosis is a wound healing process initiated in response to chronic liver damage caused by viruses, toxins, and hepatotoxic drugs. The disease is characterized by inflammation followed by deposition of extracellular matrix proteins to form scar tissue. Ephrin receptor A2 (EphA2) has been identified as a host cofactor for hepatitis C virus (HCV) entry. The plant Caesalpinia bonducella is used in a variety of systems a traditional medicine used to treat human ailments and affiliation prickly shrub belonging to the Caesalpiniaceae family found throughout the world, especially tropical region. It is a very valuable medicinal plant because all parts of the plant have medicinal properties. It was like traditional Indian herbal medicine considered an important therapeutic modality for the treatment of various diseases. As per literature survey the plants containing kaempferol and quercetin-3-methylether are traditionally utilized for the cure of cancer and liver related disorders from the immortal time. The exact mechanism of action for the hepatoprotective action of kaempferol and quercetin-3-methylether was still not revealed. With intent to propose the most probable mechanism of action of kaempferol and quercetin-3-methylether the docking based computational analysis has been performed against the hepatoprotective drug targets like PPARα enzyme.","PeriodicalId":424241,"journal":{"name":"Middle East Research Journal of Pharmaceutical Sciences","volume":"2675 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Middle East Research Journal of Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36348/merjps.2022.v02i01.004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract: Liver fibrosis is a wound healing process initiated in response to chronic liver damage caused by viruses, toxins, and hepatotoxic drugs. The disease is characterized by inflammation followed by deposition of extracellular matrix proteins to form scar tissue. Ephrin receptor A2 (EphA2) has been identified as a host cofactor for hepatitis C virus (HCV) entry. The plant Caesalpinia bonducella is used in a variety of systems a traditional medicine used to treat human ailments and affiliation prickly shrub belonging to the Caesalpiniaceae family found throughout the world, especially tropical region. It is a very valuable medicinal plant because all parts of the plant have medicinal properties. It was like traditional Indian herbal medicine considered an important therapeutic modality for the treatment of various diseases. As per literature survey the plants containing kaempferol and quercetin-3-methylether are traditionally utilized for the cure of cancer and liver related disorders from the immortal time. The exact mechanism of action for the hepatoprotective action of kaempferol and quercetin-3-methylether was still not revealed. With intent to propose the most probable mechanism of action of kaempferol and quercetin-3-methylether the docking based computational analysis has been performed against the hepatoprotective drug targets like PPARα enzyme.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
bonducella Caesalpinia的保肝潜能:分子观察
摘要:肝纤维化是由病毒、毒素和肝毒性药物引起的慢性肝损伤引起的伤口愈合过程。这种疾病的特征是炎症,然后是细胞外基质蛋白沉积形成疤痕组织。Ephrin受体A2 (EphA2)已被确定为丙型肝炎病毒(HCV)进入宿主的辅助因子。植物Caesalpinia bonducella被用于各种系统,一种用于治疗人类疾病的传统药物和隶属于caesalpinaceae家族的多刺灌木,分布在世界各地,特别是热带地区。它是一种非常有价值的药用植物,因为它的所有部分都具有药用价值。就像传统的印度草药被认为是治疗各种疾病的重要治疗方式。根据文献调查,山奈酚和槲皮素-3-甲基醚的植物从古代起就被传统地用于治疗癌症和肝脏相关疾病。山奈酚和槲皮素-3-甲基醚的保肝作用机制尚未明确。为了提出山奈酚和槲皮素-3-甲基醚最可能的作用机制,我们对PPARα酶等肝保护药物靶点进行了对接计算分析。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Composition of Lipid Based Nanoemulsion for Oral Delivery of Orlistat Study of Organophosphorus Poisoning at a Tertiary Care Teaching Hospital Flavonoids as Potent Inhibitor of SARS-CoV-2 Nsp13 Helicase: Grid Based Docking Approach Oxcarbazepine: Preformulation Studies of Authoritative Part of Formulation Design Ageing and Insulin: Inter Alia Diabetes, Obesity and Fitness Concerns
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1